Pharmaceutical intermediates
Gadobutrol Intermediates
1 pharmaceutical intermediate for Gadobutrol. Indication: Coronary artery disease; Aortic disease; Imaging examination; Breast disease; Vascular disease.
About Gadobutrol
- Originator
- Bayer Healthcare Pharmaceuticals Inc
- Indication
- Coronary artery disease; Aortic disease; Imaging examination; Breast disease; Vascular disease
- Approved Date
- 03/14/2011
Available intermediates
1 intermediate currently listed for Gadobutrol. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| Cyclen | 294-90-6 | / | / |
Other programs under G
Building toward Gadobutrol?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →